Genomic Vision SA
PAR:GV

Watchlist Manager
Genomic Vision SA Logo
Genomic Vision SA
PAR:GV
Watchlist
Price: 0.0018 EUR Market Closed
Market Cap: 694.6k EUR

Operating Margin
Genomic Vision SA

-789%
Current
-528%
Average
-5.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-789%
=
Operating Profit
-8.7m
/
Revenue
1.1m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
FR
Genomic Vision SA
PAR:GV
693.2k EUR
-789%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
US
Abbvie Inc
NYSE:ABBV
337.7B USD
30%
US
Cyclo Therapeutics Inc
NASDAQ:CYTH
325.9B USD
-2 834%
US
Amgen Inc
NASDAQ:AMGN
162.9B USD
25%
US
Gilead Sciences Inc
NASDAQ:GILD
142.2B USD
38%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.3B USD
38%
US
Epizyme Inc
F:EPE
94.1B EUR
-370%
AU
CSL Ltd
ASX:CSL
131.7B AUD
26%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
60.4B USD
29%
US
Seagen Inc
F:SGT
39.3B EUR
-33%

Genomic Vision SA
Glance View

Market Cap
693.2k EUR
Industry
Biotechnology

Génomic Vision SA is a molecular diagnostics and technology company, which develops and commercializes research tools and tests for the early detection of cancers and genetic diseases. The company is headquartered in Bagneux, Ile-De-France. The company went IPO on 2014-04-02. The company develops and commercializes single-DNA molecule diagnostic tests and research tools for life sciences, cancer and genetic diseases. The firm uses the molecular combining technique for the direct visualization of single DNA molecules to detect quantitative and qualitative changes in the genome landscape and establish their contribution to pathology. The company develops its products and services in three main markets: the medical diagnostic market focusing on DNA diagnostics (cancer genomics, genetic diseases); the pharmaceutical research and development market in the fields of genomics, to develop tests that can help physicians identify how patients are likely to respond to targeted therapies (personalized medicine, pharmacogenomics, cancer cell proliferation); and the academic laboratories research market, providing molecular combining tools for academic research in the field of cancer genetics, cytogenetics and DNA replication.

GV Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-789%
=
Operating Profit
-8.7m
/
Revenue
1.1m
What is the Operating Margin of Genomic Vision SA?

Based on Genomic Vision SA's most recent financial statements, the company has Operating Margin of -789%.

Back to Top